GlobeImmune (OTC:GBIM) Stock, Quote.Headers.trade-ideas

GlobeImmune Inc is a U.S.-based biopharmaceutical company which focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen platform. It develops few Tarmogen product candidates for infectious disease and multiple cancer indications. The pipeline products of the company are GS-4774, GI-19000, GI-2010, GI-18000 which targets HBV and HIV antigens, TB antigens and Delta virus antigens and Oncology product candidates such as GI-6207, GI-6301, GI4000 which targets Carcinoembryonic antigen, Brachyury, and Mutated Ras.

Earnings

News

Guidance

Eurozone

Commodities

Global

Intraday Update

Markets

Movers

EGLE

FORD

GBIM

SPCB

Mid-Afternoon Market Update: Crude Oil Up 2%; Supercom Shares Drop After Q1 Results

Movers & Shakers

CVGI

NVDQ

VUZI

10 Biggest Mid-Day Losers For Wednesday

ISCA

Mid-Day Market Update: U.S. Stocks Turn Positive; Nortek Shares Surge Following Acquisition News

GlobeImmune Inc

GlobeImmune

Comments

GlobeImmune

GlobeImmune (OTC:GBIM) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell